Literature DB >> 14618021

Treatment of type 1 diabetes with anti-CD3 monoclonal antibody.

Mariela Glandt1, William Hagopian, Kevan C Herold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14618021     DOI： 10.1023/a:1027354129493

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN： 1389-9155            Impact factor:   9.306


× No keyword cloud information.
  48 in total

1.  Advantages of F(ab')2 fragments of anti-CD3 monoclonal antibody as compared to whole antibody as immunosuppressive agents in mice.

Authors:  R Hirsch; J A Bluestone; C V Bare; R E Gress
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

2.  Intensive therapy in adult insulin-dependent diabetes mellitus is associated with improved insulin sensitivity and reserve: a randomized, controlled, prospective study over 5 years in newly diagnosed patients.

Authors:  T Linn; K Ortac; H Laube; K Federlin
Journal:  Metabolism       Date:  1996-12       Impact factor: 8.694

3.  CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.

Authors:  J Zhang; K V Salojin; T L Delovitch
Journal:  Int Immunol       Date:  2001-03       Impact factor: 4.823

4.  Autoantibody response to islet transplantation in type 1 diabetes.

Authors:  E Bosi; S Braghi; P Maffi; M Scirpoli; F Bertuzzi; G Pozza; A Secchi; E Bonifacio
Journal:  Diabetes       Date:  2001-11       Impact factor: 9.461

5.  Modified anti-CD3 therapy in psoriatic arthritis: a phase I/II clinical trial.

Authors:  Tammy O Utset; Julie A Auger; Donna Peace; Robert A Zivin; Danlin Xu; Linda Jolliffe; Maria-Luisa Alegre; Jeffrey A Bluestone; Marcus R Clark
Journal:  J Rheumatol       Date:  2002-09       Impact factor: 4.666

6.  Cytokine gene expression in islets and thyroids of BB rats. IFN-gamma and IL-12p40 mRNA increase with age in both diabetic and insulin-treated nondiabetic BB rats.

Authors:  D Zipris; D L Greiner; S Malkani; B Whalen; J P Mordes; A A Rossini
Journal:  J Immunol       Date:  1996-02-01       Impact factor: 5.422

7.  Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

Authors:  Kevan C Herold; Joshua B Burton; Fleur Francois; Ena Poumian-Ruiz; Mariela Glandt; Jeffrey A Bluestone
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

8.  Factors associated with early remission of type I diabetes in children treated with cyclosporine.

Authors:  P F Bougneres; J C Carel; L Castano; C Boitard; J P Gardin; P Landais; J Hors; M J Mihatsch; M Paillard; J L Chaussain
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

9.  Regulation of cytokine production during development of autoimmune diabetes induced with multiple low doses of streptozotocin.

Authors:  K C Herold; V Vezys; Q Sun; D Viktora; E Seung; S Reiner; D R Brown
Journal:  J Immunol       Date:  1996-05-01       Impact factor: 5.422

Review 10.  Type 1 T regulatory cells.

Authors:  M G Roncarolo; R Bacchetta; C Bordignon; S Narula; M K Levings
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988
View more
  2 in total

1.  Acquisition of regulatory function by human CD8(+) T cells treated with anti-CD3 antibody requires TNF.

Authors:  Vitaly Ablamunits; Brygida Bisikirska; Kevan C Herold
Journal:  Eur J Immunol       Date:  2010-10       Impact factor: 5.532

Review 2.  Targeted immune interventions for type 1 diabetes: not as easy as it looks!

Authors:  Mark R Rigby; Mario R Ehlers
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-08       Impact factor: 3.243
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.